Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial

Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added detailed Locations sections for numerous US states (California, Colorado, Illinois, Iowa, Kansas, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Texas) and international sites (Victoria, Emilia-Romagna, Lombardy) and updated the revision to v3.3.3. Removed the previous location lists (v3.3.2 reference) and updated the revision accordingly.
    Difference
    1%
    Check dated 2025-12-22T22:20:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.3.2 has been added, replacing the prior v3.3.1.
    Difference
    0.0%
    Check dated 2025-12-01T16:30:35.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.1 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T11:43:26.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    - Removed a boilerplate government funding status notice from the top of the page.
    Difference
    0.3%
    Check dated 2025-11-17T06:18:29.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    No substantive changes were detected; the page continues to present the study details, eligibility criteria, and participating locations as before.
    Difference
    0.3%
    Check dated 2025-11-03T00:56:07.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    1%
    Check dated 2025-10-05T08:15:57.000Z thumbnail image

Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.